NDAORALCAPSULE
Approved
May 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Clinical Trials (5)
A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions
Started Mar 2026
24 enrolled
Healthy
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
Started Feb 2026
50 enrolled
Transthyretin Amyloid Cardiomyopathy
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Started Jun 2025
15 enrolled
Transthyretin Amyloid Polyneuropathy
A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults
Started Dec 2024
22 enrolled
Healthy
Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy
Started Jun 2024
50 enrolled
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Loss of Exclusivity
LOE Date
Aug 31, 2035
115 months away
Patent Expiry
Aug 31, 2035
Exclusivity Expiry
May 3, 2026